Radiotherapy for low-grade gastric marginal zone lymphoma: A retrospective study

Internal Medicine Journal

Volumn 37, Issue 3, 2007, Pages 172-180

  Lin, M L ^a   Wirth, A ^a   Chao, M ^b   Milner, A D ^a   Diiulio, J ^a   MacManus, M ^a   Seymour, J F ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b Radiation Oncology Victoria   (Australia)

Author keywords

Gastric marginal zone lymphoma; Mucosa associated lymphoid tissue; Radiotherapy

Indexed keywords

ANTIBIOTIC AGENT; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; STOMACH SECRETION INHIBITOR; VINCRISTINE;

ACUTE TOXICITY; ADULT; AGED; BIOPSY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; ERADICATION THERAPY; FEMALE; FOLLOW UP; GASTRIC MARGINAL ZONE LYMPHOMA; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; INTESTINE; LYMPH NODE; MALE; NEPHROTOXICITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION FIELD; RADIATION RESPONSE; REMISSION; RETROSPECTIVE STUDY; REVIEW; STOMACH; STOMACH LYMPHOMA; TREATMENT WITHDRAWAL;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BIOPSY; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HELICOBACTER INFECTIONS; HUMANS; LYMPHOMA, LOW-GRADE; MALE; MEDICAL RECORDS; MIDDLE AGED; NEOPLASM STAGING; RETREATMENT; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 33846966261     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2006.01291.x     Document Type: Review

References (40)

1. Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer 1983; 52: 1410-16.
2. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575-7.
3. Pinotti G, Zucca E, Roggero E, Pascarella A, Bertoni F, Savio A et al. Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma. Leuk Lymphoma 1997; 26: 527-37.
4. Stolte M, Bayerdorffer E, Morgner A, Alpen B, Wundisch T, Thiede C et al. Helicobacter and gastric MALT lymphoma. Gut 2002; 50(Suppl. 3): III19-24.
5. Wundisch T, Thiede C, Morgner A, Dempfle A, Gunther A, Liu H et al. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol 2005; 23: 8018-24.
6. Sandmeier D, Benhattar J, Bouzourene H. The natural history of a gastric low grade B cell MALT lymphoma followed during 11 years without treatment. J Clin Pathol 2002; 55: 548-50.
7. de Jong D, Aleman BM, Taal BG, Boot H. Controversies and consensus in the diagnosis, work-up and treatment of gastric lymphoma: an international survey. Ann Oncol 1999; 10: 275-80.
8. Gospodarowicz MK, Pintilie M, Tsang R, Patterson B, Bezjak A, Wells W. Primary gastric lymphoma: brief overview of the recent Princess Margaret Hospital experience. Recent Results Cancer Res 2000; 156: 108-15.
9. Schechter NR, Yahalom J. Low-grade MALT lymphoma of the stomach: a review of treatment options. Int J Radiat Oncol Biol Phys 2000; 46: 1093-103.
10. Tsang RW, Gospodarowicz MK, Pintilie M, Wells W, Hodgson DC, Sun A et al. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol 2003; 21: 4157-64.
11. Rohatiner A, d'Amore F, Coiffier B, Crowther D, Gospodarowicz M, Isaacson P et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 1994; 5: 397-400.
12. Altman DG, De Stavola BL, Love SB, Stepniewska KA. Review of survival analyses published in cancer journals. Br J Cancer 1995; 72: 511-18.
13. Bertoni F, Zucca E. State-of-the-art therapeutics: marginal-zone lymphoma. J Clin Oncol 2005; 23: 6415-20.
14. Inagaki H, Nakamura T, Li C, Sugiyama T, Asaka M, Kodaira J et al. Gastric MALT lymphomas are divided into three groups based on responsiveness to Helicobacter pylori eradication and detection of API2-MALT1 fusion. Am J Surg Pathol 2004; 28: 1560-67.
15. Liu H, Ye H, Ruskone-Fourmestraux A, De Jong D, Pileri S, Thiede C et al. T(11;18) is amarker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 2002; 122: 1286-94.
16. Levy M, Hammel P, Lamarque D, Marty O, Chaumette MT, Haioun C et al. Endoscopic ultrasonography for the initial staging and follow-up in patients with low-grade gastric lymphoma of mucosa-associated lymphoid tissue treated medically. Gastrointest Endosc 1997; 46: 328-33.
17. Caletti G, Fusaroli P, Togliani T. EUS in MALT lymphoma. Gastrointest Endosc 2002; 56(4 Suppl.): S21-6.
18. Nakamura S, Matsumoto T, Suekane H, Matsumoto H, Esaki M, Yao T et al. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment. Cancer 2005; 104: 532-40.
19. Ruskone-Fourmestraux A, Lavergne A, Aegerter PH, Megraud F, Palazzo L, de Mascarel A et al. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. Gut 2001; 48: 297-303.
20. Levy M, Copie-Bergman C, Traulle C, Lavergne-Slove A, Brousse N, Flejou JF et al. Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome. Am J Gastroenterol 2002; 97: 292-7.
21. Yoon SS, Coit DG, Portlock CS, Karpeh MS. The diminishing role of surgery in the treatment of gastric lymphoma. Ann Surg 2004; 240: 28-37.
22. Tsang RW, Gospodarowicz MK. Radiation therapy for localized low-grade non-Hodgkin's lymphomas. Hematol Oncol 2005; 23: 10-17.
23. Koch P, del Valle F, Berdel WE, Willich NA, Reers B, Hiddemann W et al. Primary gastrointestinal non-Hodgkin's lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma - results of the prospective German Multicenter Study GIT NHL 01/92. J Clin Oncol 2001; 19: 3874-83.
24. Manoharan A. Sustained remissions with long-term weekly chlorambucil maintenance therapy in patients with mucosa-associated lymphoid tissue lymphoma. Int J Hematol 2004; 79: 472-3.
25. Hammel P, Haioun C, Chaumette MT, Gaulard P, Divine M, Reyes F et al. Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression. J Clin Oncol 1995; 13: 2524-9.
26. Conconi A, Martinelli G, Thieblemont C, Ferreri AJ, Devizzi L, Peccatori F et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 2003; 102: 2741-5.
27. Martinelli G, Laszlo D, Ferreri AJ, Pruneri G, Ponzoni M, Conconi A et al. Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy. J Clin Oncol 2005; 23: 1979-83.
28. Kodera Y, Yamamura Y, Nakamura S, Shimizu Y, Torii A, Hirai T et al. The role of radical gastrectomy with systematic lymphadenectomy for the diagnosis and treatment of primary gastric lymphoma. Ann Surg 1998; 227: 45-50.
29. Wotherspoon AC, Doglioni C, Isaacson PG. Low-grade gastric B-cell lymphoma of mucosa-associated lymphoid tissue (MALT): amultifocal disease. Histopathology 1992; 20: 29-34.
30. El-Modir A, Glaholm J. Gastric irradiation for low-grade MALT lymphoma of the stomach: report of two cases and review of the literature. Clin Oncol (R Coll Radiol) 2002; 14: 464-7.
31. Koch P, Probst A, Berdel WE, Willich NA, Reinartz G, Brockmann J et al. Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96). J Clin Oncol 2005; 23: 7050-59.
32. Schechter NR, Portlock CS, Yahalom J. Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. J Clin Oncol 1998; 16: 1916-21.
33. Yahalom J, Schechter N, Gonzales M, Moskowitz C, Noy A, Straus D et al. H. pylori-independent MALT lymphoma of the stomach: 10-year experience with 51 patients treated with radiation alone. Ann Oncol 2002; 13 Suppl. 13: 42-3.
34. Burgers JM, Taal BG, van Heerde P, Somers R, den Hartog Jager FC, Hart AA. Treatment results of primary stage I and II non-Hodgkin's lymphoma of the stomach. Radiother Oncol 1988; 11: 319-26.
35. Nakamura S, Matsumoto T, Suekane H, Matsumoto H, Esaki M, Yao T et al. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment. Cancer 2005; 104: 532-40.
36. Thieblemont C, Dumontet C, Bouafia F, Hequet O, Arnaud P, Espinouse D et al. Outcome in relation to treatment modalities in 48 patients with localized gastric MALT lymphoma: a retrospective study of patients treated during 1976-2001. Leuk Lymphoma 2003; 44: 257-62.
37. Wirth A, Teo A, Wittwer H, MacManus M, Ryan G. Gastric irradiation for MALT lymphoma: reducing the target volume, fast! Australas Radiol 1999; 43: 87-90.
38. Zucca E, Pinotti G, Roggero E, Comi MA, Pascarella A, Capella C et al. High incidence of other neoplasms in patients with low-grade gastric MALT lymphoma. Ann Oncol 1995; 6: 726-8.
39. Morgner A, Miehlke S, Stolte M, Neubauer A, Alpen B, Thiede C et al. Development of early gastric cancer 4 and 5 years after complete remission of Helicobacter pylori associated gastric low grade marginal zone B cell lymphoma of MALT type. World J Gastroenterol 2001; 7: 248-53.
40. Montalban C, Castrillo JM, Lopez-Abente G, Abraira V, Serrano M, Bellas C et al. Other cancers in patients with gastric MALT lymphoma. Leuk Lymphoma 1999; 33: 161-8.